Physician profile
Benjamin Adler
NPI 1598516007
$296.88
in general payments reported to CMS, 2019-2025
9 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $105 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $60.38 | 2025 | |
| Pharmaessentia USA Corporation | $48.61 | 2024 | Besremi |
| Pfizer INC. | $37.48 | 2024-2025 | |
| Abbvie INC. | $34.83 | 2025 | |
| Stemline Therapeutics INC. | $26.15 | 2025 | Orserdu |
| Rigel Pharmaceuticals, INC. | $25.48 | 2025 | Tavalisse |
| Shield Therapeutics INC | $24.03 | 2024 | |
| Alnylam Pharmaceuticals INC. | $23.62 | 2025 | Amvuttra |
| Agios Pharmaceuticals, INC. | $16.30 | 2024 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.